Huntingdon crashes on return
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SHARES IN Huntingdon Life, the troubled drug testing company, crashed 30 per cent yesterday on their first day of trading after a 10- day suspension.
The stock closed down 6p at 13.5p, the worst performer on the London stock market. The shares were restored to the list after Monday's announcement of a refinancing package which involves a pounds 20m cash injection from a group of investors.
As part of the package, which has to be approved by shareholders at an extraordinary meeting on 2 September, Andrew Baker, a 49-year-old accountant, will become executive chairman. Huntingdon has been targeted by animal rights groups and has attributed the loss of lucrative contracts on this adverse publicity.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments